Investigating pain mechanisms in patients with spinal cord injuries

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

University of Zurich · NCT06443281

This study is trying to understand how spinal cord injuries cause nerve pain by looking at how the body processes pain and responds to it in people with different types of spinal injuries and nerve issues.

Quick facts

Study typeObservational
Enrollment300 (estimated)
Ages18 Years to 80 Years
SexAll
SponsorUniversity of Zurich (other)
Locations1 site (Zurich, Canton of Zurich)
Trial IDNCT06443281 on ClinicalTrials.gov

What this trial studies

This observational study aims to explore the underlying mechanisms of neuropathic pain following spinal cord injury (SCI). It employs advanced sensory and pain phenotyping techniques, including quantitative sensory testing and neurophysiological measures, to assess pain processing and autonomic responses. The study will also examine the relationship between the somatosensory and autonomic nervous systems in the context of neuropathic pain development and maintenance. Participants will include individuals with various types of spinal injuries and control cohorts with peripheral neuropathy.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 18-80 with spinal cord injuries or peripheral neuropathy, both with and without neuropathic pain.

Not a fit: Patients with conditions unrelated to spinal cord injury or peripheral neuropathy may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of neuropathic pain in spinal cord injury patients.

How similar studies have performed: Other studies have shown promise in understanding pain mechanisms in similar populations, suggesting potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal injury cohort - general inclusion criteria:
* Aged between 18-80 years
* Traumatic and non-traumatic etiology
* Para- and tetraplegic SCI
* Complete and incomplete SCI
* SCI with and without neuropathic pain
* Additional inclusion criteria for longitudinal study:
* SCI since less than one month
* Additional inclusion criteria for cross-sectional study:
* SCI since more than one year
* Control cohorts with peripheral neuropathy:
* General inclusion criteria:
* Aged between 18-80 years
* Neurological disorder affecting the peripheral nervous system (i.e., peripheral neuropathy)
* Peripheral neuropathy with or without neuropathic pain
* Additional inclusion criteria for longitudinal study:
* Peripheral neuropathy since less than one month
* Additional inclusion criteria for cross-sectional study:
* Peripheral neuropathy since more than one year
* Control cohorts without neuropathy / healthy volunteers
* General inclusion criteria:
* Aged between 18-80 years
* No medical condition affecting the peripheral and/or central nervous system (e.g., pain, systemic disease, psychological disorder)

Exclusion Criteria:

* Inability to follow study instructions
* Pregnancy
* Medically manifested psychological disorder
* Medical condition affecting the peripheral and/or central nervous system other than the desired experimental condition (e.g., additional peripheral neuropathy in the SCI cohort)

Where this trial is running

Zurich, Canton of Zurich

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Spinal Cord Injuries, Pain, Neuropathic, Nociceptive Pain, Neuropathy

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.